Probiotics in the United States

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 2, 2008, Pages

  Vanderhoof, Jon A ^a,b   Young, Rosemary ^c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Mead Johnson Nutritionals   (United States)

^c BOYS TOWN NATIONAL RESEARCH HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

CONFERENCE PAPER; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DRUG USE; GASTROINTESTINAL TRACT; HUMAN; LACTOBACILLUS RHAMNOSUS; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SCIENCE; THERAPY EFFECT; TRAVELLER DIARRHEA; UNITED STATES;

CONSUMER PRODUCT SAFETY; FEMALE; FOOD MICROBIOLOGY; GOVERNMENT REGULATION; HEALTH FOOD; HUMANS; NUTRITION THERAPY; PROBIOTICS; UNITED STATES;

EID: 40049089730     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/523339     Document Type: Conference Paper

References (64)

1. Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria: report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Córdoba, Argentina, 1-4 October 2001. Available at: ftp://ftp.fao.org/docrep/fao/meeting/ 009/y6398e.pdf. Accessed 14 December 2007.
2. Metchnikoff E. The prolongation of life. New York: Putnam & Sons, 1908.
3. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999; 69:1035S-45S.
4. Dai D, Walker WA. Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr 1999; 46:353-82.
5. Drewnowski A, Gomez-Carneros C. Bitter taste, phytonutrients, and the consumer: a review. Am J Clin Nutr 2000; 72:1424-35.
6. Federal Trade Commission, US Food and Drug Administration. "Miracle" health claims: add a dose of skepticism. 2001. Available at: http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea07.shtm. Accessed 14 December 2007.
7. Lu L, Walker WA. Pathologic and physiologic interactions of bacteria with the gastrointestinal epithelium. Am J Clin Nutr 2001; 73:1124S-30S.
8. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001; 33(Suppl 2):S17-25.
9. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47:2625-34.
10. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344:1046-9.
11. Agostoni C, Axelsson I, Braegger C, et al. Probiotic bacteria in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2004; 38:365-74.
12. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2004; 2:CD003048.
13. Billoo AG, Memon MA, Khaskheli SA, et al. Role of a probiotic (Saccharomyces boulardii) in the management and prevention of diarrhea. World J Gastroenterol 2006; 12:4557-60.
14. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2007; 2:CD004827.
15. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhoea in children with respiratory infections: a randomized study. Pediatrics 1999; 104:e64.
16. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhoea in children. J Pediatr 1999; 135:564-8.
17. Segarra-Newnham M. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Ann Pharmacother 2007; 41:1212-21.
18. Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21:224-6.
19. Karpa KD. Probiotics for Clostridium difficile diarrhea: putting it into perspective. Ann Pharmacother 2007; 41:1284-7.
20. Hilton E, Kolakowski P, Smith M, Singer C. Efficacy of Lactobacillus GG as a diarrheal preventative in travelers. J Travel Med 1997; 4:41-3.
21. Oksanen P, Salminen S, Saxelin M, et al. Prevention of traveller's diarrhoea by Lactobacillus GG. Ann Med 1990; 22:53-6.
22. Takahashi O, Noguchi Y, Omata F, Tokuda Y, Fukui T. Probiotics in the prevention of traveler's diarrhea: meta-analysis. J Clin Gastroenterol 2007; 41:336-7.
23. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007; 5:97-105.
24. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000; 30:1604-10.
25. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-9.
26. Del Giudice MM, Rocco A, Capristo C. Probiotics in the atopic march: highlights and new insights. Dig Liver Dis 2006; 38(Suppl 2):S288-90.
27. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; 90:892-7.
28. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119:305-9.
29. Shen B, Brzezinski A, Fazio VW, et al. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice. Aliment Pharmacol Ther 2005; 22:721-8.
30. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128:541-51.
31. Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr 2006; 25:514-22.
32. Adler SN. The probiotic agent Escherichia coli M-17 has a healing effect in patients with IBS with proximal inflammation of the small bowel. Dig Liver Dis 2006; 38:713.
33. Hatakka K, Martio J, Korpela M, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand J Rheumatol 2003; 32:211-5.
34. Gupta P, Andrew H, Kirschner BS, Guandalini S. Is Lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000; 31:453-7.
35. Bousvaros A, Guandalini S, Baldassano RN, et al. A randomized double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 2005; 11:833-9.
36. Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol 2000; 95(Suppl 1):S19-21.
37. Sheil B, Shanahan F, O'Mahony L. Probiotic effects on inflammatory bowel disease. J Nutr 2007; 137(Suppl 2):819S-24S.
38. Jones JL, Foxx-Orenstein AE. The role of probiotics in inflammatory bowel disease. Dig Dis Sci 2007; 52:607-11.
39. Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006; 130(Suppl 1):S78-90.
40. Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 1998; 27:155-60.
41. Gaon D, Garmendia C, Murrielo NO, et al. Effect of Lactobacillus strains (L. casei and L. acidophillus strains Cerela) on bacterial overgrowth-related chronic diarrhea. Medicina (B Aires) 2002; 62:159-63.
42. Anderson MH, Shi W. A probiotic approach to caries management. Pediatr Dent 2006; 28:151-3.
43. Ahola AJ, Yli-Knuuttila H, Suomalainen T, et al. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Arch Oral Biol 2002; 47:799-804.
44. Hatakka K, Savilahti E, Ponka A, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001; 322:1327.
45. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-8.
46. de Vrese M, Stegelmann A, Richter B, et al. Probiotics-compensation for lactase insufficiency. Am J Clin Nutr 2001; 73(Suppl 2):421S-9S.
47. Hove H, Norgaard H, Mortensen PB. Lactic acid bacteria and the human gastrointestinal tract. Eur J Clin Nutr 1999; 53:339-50.
48. Geier MS, Butler RN, Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer? Cancer Biol Ther 2006; 5:1265-9.
49. Goldin BR, Gualtieri LJ, Moore RP. The effect of Lactobacillus GG on the initiation and promotion of dimethylhydrazine-induced intestinal tumors in the rat. Nutr Cancer 1996; 25:197-204.
50. Burns AJ, Rowland IR. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat Res 2004; 551:233-43.
51. Nguyen TD, Kang JH, Lee MS. Characterization of Lactobacillus plantarum PH04, a potential probiotic bacterium with cholesterol-lowering effects. Int J Food Microbiol 2007; 113:358-61.
52. Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol 2002; 37:259-81.
53. Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998; 27:323-32.
54. Guarino A, Berni Canani R, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 1997; 25:516-9.
55. Schultz M, Veltkamp C, Dieleman LA, et al. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002; 8:71-80.
56. BCC Research. Probiotics: ingredients, supplements, foods. 2005. Available at: http://www.the-infoshop.com/study/bc31434-probiotics.html. Accessed February 2006.
57. Canadian Ministry of Health. Evidence for quality of finished natural health products: natural health products directorate. 2007. Available at: http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/eq-paq_e.html#218. Accessed June 2007.
58. Shimizu T. Newly established regulation in Japan: foods with health claims. Asia Pac J Clin Nutr 2002; 11:S94-6.
59. Hathcock J. Dietary supplements: how they are used and regulated. J Nutr 2001; 131:1114S-7S.
60. Burdock GA. Dietary supplements and lessons to be learned from GRAS. Regul Toxicol Pharmacol 2000; 31:68-76.
61. Jones JR, Lineback DM, Levine MJ. Dietary reference intakes: implications for fiber labeling and consumption: a summary of the International Life Sciences Institute North America Fiber Workshop, June 1-2, 2004, Washington, DC. Nutr Rev 2006; 64:31-8.
62. Gibson JE, Taylor DA. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States? J Pharmacol Exp Ther 2005; 314:939-44.
63. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001; 73(Suppl 2):465S-70S.
64. Salminen S, von Wright A, Morelli L, et al. Demonstration of safety of probiotics - a review. Int J Food Microbiol 1998; 44:93-106.